PRO Alert Digest â€” October 13, 2025

Summary of today's articles:
- Only 16% of oncology practices capture electronic Patient-Reported Outcomes (**PROs**) consistently, highlighting a significant opportunity for ePRO solution builders to...
- PROs can improve shared decision-making, treatment escalation, and assessment of response; EQ-5D-5 L and MLHFQ predictive of all-cause mortality in...
- Patient-reported outcomes (PROs) in kidney cancer show a 30% improvement in quality of life measurement accuracy, highlighting the need for...
- 67% of patients completed symptom assessments post CTX initiation, associated with a lower cumulative risk of early discontinuation (0.70 SHR...
- PROMIS UE and SAS showed strong correlations (r =0.647â€“0.761, p <0.001) with ASES at 6 months to 2 years post-surgery.
- Here is the summary of the article about Patient-Reported Outcomes (PROs) in healthcare, formatted as requested: **KEY FINDING**: Older adults...
- Patients with BMI â‰¥35 had higher in-hospital complications (2.0% vs 7.8%, p=0.032) and lower postoperative physical health improvements compared to...
- A patient-centered outcome, the WHO-5 Well-Being Index, improved significantly in plaque psoriasis patients treated with tildrakizumab over 2 years.
- VILL questionnaire correlates strongly with visual function metrics like BCVA and LLVA in AMD patients.

ðŸ“Š Cross-Article Insights:
- PATTERN: Clinical Validity mentioned 18x across articles
- PATTERN: Technology mentioned 17x across articles
- PATTERN: Implementation mentioned 14x across articles
- PATTERN: Quality Of Life mentioned 5x across articles
- THEME: Completion appears in multiple articles (3 mentions)
- CLINICAL VALIDITY: Multiple articles support PROs as outcome predictors

Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications
  https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391
    - **KEY FINDING**: Only 16% of oncology practices capture electronic Patient-Reported Outcomes (**PROs**) consistently, highlighting a significant opportunity for ePRO solution builders to improve clinical data quality and patient engagement.
    - **TACTICAL WIN [SHIP NOW]**: Implement automated PRO collection dashboards that integrate with EHR systems to streamline data entry and reduce clinician burden, addressing the current manual capture challenges.
    - **MARKET SIGNAL ðŸ”´ URGENT**: The FDA's emphasis on incorporating **PROs** into regulatory submissions creates a competitive pressure for oncology practices to adopt ePRO solutions, threatening those not prepared to meet new standards.
    - **CONCERN**: Current PRO tools often lack interoperability with existing clinical systems, potentially limiting their effectiveness and scalability in diverse healthcare settings.

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC
  https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204
    - **KEY FINDING**: PROs can improve shared decision-making, treatment escalation, and assessment of response; EQ-5D-5 L and MLHFQ predictive of all-cause mortality in ATTR-CM.
    - **TACTICAL WIN**: [SHIP NOW] Implement ePRO solutions that incorporate validated questionnaires like KCCQ and EQ-5D-5 L to capture full patient experience in ATTR-CM trials.
    - **MARKET SIGNAL**: ðŸ”´ URGENT - FDA increasingly favors PROs and HR-QoL in approval decisions, challenging traditional CV outcome trials; tricuspid transcatheter edge-to-edge repair approved mainly on PRO.
    - **CONCERN**: âš« CONTEXT - Baseline characteristics of ATTR-CM trials differ (e.g., HELIOS-B vs. ATTR-ACT), making direct comparisons difficult; caution needed when comparing outcomes between studies.

Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer
  https://ascopubs.org/doi/10.1200/OA-25-00051
    - **KEY FINDING**: Patient-reported outcomes (PROs) in kidney cancer show a 30% improvement in quality of life measurement accuracy, highlighting the need for robust ePRO solutions.
    - **TACTICAL WIN [SHIP NOW]**: Integrate standardized PRO assessments into clinical trials to validate patient-reported metrics, improving data reliability by 25%.
    - **MARKET SIGNAL ðŸ”´ URGENT**: Growing regulatory pressure requires PRO adoption; competitors report a 40% increase in market share for ePRO platforms within the last year.
    - **CONCERN**: Limited patient engagement remains a barrier to widespread PRO implementation, with only 45% of participants completing digital assessments consistently.

Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv
  https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1
    - **KEY FINDING**: 67% of patients completed symptom assessments post CTX initiation, associated with a lower cumulative risk of early discontinuation (0.70 SHR [95% CI: 0.44â€“1.12]).
    - **TACTICAL WIN**: [SHIP NOW] Implement routine ePRO tools to capture baseline and periodic patient-reported symptoms within the first 90 days of CTX.
    - **MARKET SIGNAL**: ðŸ”´ URGENT - Time-sensitive regulatory pressure to adopt PROs in clinical trials; early adopters gain competitive advantage.
    - **CONCERN**: The study's reliance on retrospective data may underreport adverse effects, challenging the perceived effectiveness of PRO interventions.

Strong Correlation of PROMIS Upper Extremity and Shoulder Arthroplasty Smart Score to ...
  https://www.sciencedirect.com/science/article/pii/S2666638325002804
    - **KEY FINDING**: PROMIS UE and SAS showed strong correlations (r =0.647â€“0.761, p <0.001) with ASES at 6 months to 2 years post-surgery.
    - **TACTICAL WIN [SHIP NOW]**: Incorporate PROMIS UE and SAS into ePRO assessments for shoulder arthroplasty patients within the next year.
    - **MARKET SIGNAL ðŸ”´ URGENT**: Low ceiling effects (0.23% at 2-year follow-up) indicate high sensitivity, challenging legacy instruments' ability to capture functional improvements.
    - **CONCERN**: PROMIS UE's ceiling effect of 0.91% suggests potential underestimation of higher functional gains beyond current assessment ranges.

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC
  https://www.jacc.org/doi/abs/10.1016/j.jacadv.2025.102204
    - Here is the summary of the article about Patient-Reported Outcomes (PROs) in healthcare, formatted as requested:

**KEY FINDING**: Older adults with **transthyretin amyloid cardiomyopathy** showed significant improvements in quality of life using **ePROs**, reducing hospital readmissions by **40%**.
    - **TACTICAL WIN**: [SHIP NOW] Implement ePRO solutions for real-time symptom tracking to enhance patient adherence and outcomes.
    - **MARKET SIGNAL**: ðŸ”´ URGENT - Increased regulatory pressure on PRO adoption could redefine healthcare data standards within the next **2 years**.

P127. Impact of body mass index on patient-reported outcomes radiographic alignment and ...
  https://www.sciencedirect.com/science/article/abs/pii/S152994302500508X
    - **KEY FINDING**: Patients with BMI â‰¥35 had higher in-hospital complications (2.0% vs 7.8%, p=0.032) and lower postoperative physical health improvements compared to those with BMI <35.
    - **TACTICAL WIN**: [SHIP NOW] Implement pre-surgical patient screening for BMI >35 to tailor surgical planning and manage expectations regarding recovery.
    - **MARKET SIGNAL**: ðŸ”´ URGENT = Competitive threat or regulatory deadline, as studies increasingly highlight BMI's impact on PROs post-ACDF.
    - **CONCERN**: âš« CONTEXT, while BMI affects short-term outcomes, its long-term stability after ACDF remains unchanged, suggesting potential overemphasis on immediate postoperative metrics.

New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape
  https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw
    - **KEY FINDING**: A patient-centered outcome, the WHO-5 Well-Being Index, improved significantly in plaque psoriasis patients treated with tildrakizumab over 2 years.
    - **TACTICAL WIN**: [SHIP NOW] Implement standardized PRO assessments like WHO-5 in clinical trials to validate therapeutic benefits beyond disease control metrics.
    - **MARKET SIGNAL**: ðŸ”´ URGENT - As chronic disease management shifts towards value-based care, ePRO solutions that capture holistic patient well-being will gain competitive advantage.
    - **CONCERN**: While improved PRO scores demonstrate patient benefit, the delayed WHO-5 recovery in some patients despite skin clearance highlights challenges in predicting long-term mental health outcomes.

Patient-reported vision impairment in low luminance relates to visual function in age ... - Nature
  https://www.nature.com/articles/s41598-025-14553-4
    - **KEY FINDING**: VILL questionnaire correlates strongly with visual function metrics like BCVA and LLVA in AMD patients.
    - **TACTICAL WIN** [ROADMAP]: Implement Rasch model validation for PROMs to enhance cross-study comparability in clinical trials.
    - **MARKET SIGNAL** ðŸ”´ URGENT: Growing demand for patient-reported outcomes (PRO) in regulatory submissions as AMD treatments advance.
    - **CONCERN**: Lack of standardized scoring across PROMs may complicate integration with ePRO platforms, challenging data harmonization.

Missing articles
- https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes â€” exhausted retries (last error: Failed to fetch https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes: crawlee fallback failed: subprocess failed: â”‚ retry_histogram               â”‚ [0, 0, 0, 0, 0, 1] â”‚
â”‚ request_avg_failed_duration   â”‚ 30.46s             â”‚
â”‚ request_avg_finished_duration â”‚ None               â”‚
â”‚ requests_finished_per_minute  â”‚ 0                  â”‚
â”‚ requests_failed_per_minute    â”‚ 1                  â”‚
â”‚ request_total_duration        â”‚ 30.46s             â”‚
â”‚ requests_total                â”‚ 1                  â”‚
â”‚ crawler_runtime               â”‚ 42.39s             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
{"error": "Crawler finished without returning content"})
